SSKN · STRATA Skin Sciences, Inc.
$0.01
+0.00 (+10.00%)
At close · Jul 27
Going-concern doubt
— flagged Mar 26, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Our history of operating losses and current default on our long-term debt raise substantial doubt regarding our ability to continue as a going concern.”View the 10-K filed Mar 26, 2026
Market Cap
$32,385
Shares
5.89M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$30.7M
-8.5%
FY2025
Net Income
-$6.26M
+37.9%
FY2025
Gross Margin
58.25%
+1.4pp
FY2025
Operating Margin
-15.31%
+12.3pp
FY2025
Diluted EPS
-$1.35
+49.1%
FY2025
Operating Cash Flow
-$2.79M
-1586.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | $30.7M | $33.56M | $33.36M | $36.16M | $29.98M | $23.09M | $31.59M | $29.86M | $31.45M | $31.76M | $18.5M | $915K | $536K | $278.46K | — | |
| -$116K | — | — | — | — | — | -$61K | — | — | — | — | — | — | — | — | — | |
| — | $12.82M | $14.48M | $14.9M | $14.39M | $10.13M | $8.96M | $11.32M | $12.74M | $13.5M | $12.64M | $13.72M | $4.94M | $4.34M | $2.04M | — | |
| — | $17.88M | $19.08M | $18.46M | $21.77M | $19.85M | $14.13M | $20.27M | $17.12M | $17.95M | $19.12M | $4.78M | -$4.02M | -$3.81M | -$1.76M | — | |
| — | 58.25% | 56.85% | 55.34% | 60.2% | 66.22% | 61.21% | 64.17% | 57.34% | 57.08% | 60.21% | 25.82% | -439.34% | -709.89% | -633.44% | — | |
| — | $421K | $883K | $1.32M | $1.03M | $1.43M | $1.27M | $1M | $1.07M | $1.71M | $1.93M | $2.03M | $1.64M | $3.78M | $6.79M | $9.66M | |
| — | $13.11M | $12.29M | $12.96M | $15.3M | $13.11M | $9.04M | $12M | $10.62M | $11.25M | $13.15M | — | — | — | — | — | |
| — | $10.18M | $11.3M | $10.51M | $10.09M | $9.71M | $7.9M | $10.28M | $8.79M | $7.4M | $7.64M | $10.03M | — | $15.54M | $14.17M | $10.81M | |
| — | — | — | — | — | — | — | — | — | — | — | $9.19M | $10.96M | — | — | — | |
| — | $1.2M | $2M | $2.7M | $2.9M | $1.6M | $1.61M | $1.81M | $1.83M | $2M | — | — | — | — | — | — | |
| — | $4.12M | $4.97M | $5.55M | $2.4M | $2.1M | $1.98M | $2.69M | $3.56M | $4.34M | $4.55M | $3.14M | $1.79M | $2.44M | $969.5K | $562.8K | |
| — | — | — | — | — | $24.25M | $18.21M | $23.28M | $20.48M | $20.36M | $22.72M | $21.25M | $12.6M | $20.33M | — | — | |
| — | $22.58M | $28.34M | $27.07M | $26.42M | — | — | — | — | — | — | — | — | — | — | — | |
| — | -$4.7M | -$9.26M | -$8.6M | -$4.65M | -$4.4M | -$4.08M | -$3.01M | -$3.36M | -$2.41M | -$3.6M | -$16.48M | -$16.62M | -$24.13M | -$22.72M | -$20.46M | |
| — | -15.31% | -27.58% | -25.79% | -12.86% | -14.68% | -17.65% | -9.53% | -11.24% | -7.66% | -11.33% | -89.08% | -1816.61% | -4502.61% | -8160.77% | — | |
| — | -$577K | -$4.29M | -$3.05M | -$2.25M | -$2.3M | -$2.1M | -$317K | $208K | $1.93M | $954K | -$13.33M | -$14.83M | -$21.7M | -$21.76M | -$19.9M | |
| — | $1.96M | $2.11M | $1.64M | $926K | $314K | — | $515K | $1.14M | $4.61M | $4.9M | $10.2M | $2.38M | $564K | — | — | |
| — | $410K | $242K | $231K | $89K | $15K | — | — | — | — | — | — | $8000 | $8000 | $32.03K | $54.37K | |
| — | -$1.55M | -$1M | -$2.32M | -$837K | $1.73M | -$61K | -$929K | -$942K | -$16.29M | $517K | -$8.35M | $2.48M | -$1.81M | $52.03K | $77.52K | |
| — | -$6.25M | -$10.26M | -$10.92M | -$5.49M | -$2.67M | -$4.14M | -$3.94M | -$4.3M | -$18.7M | -$3.08M | -$24.83M | — | — | — | — | |
| — | $12K | -$170K | -$92K | $63K | $34K | $275K | -$149K | -$264K | $129K | $255K | $119K | $0 | — | — | — | |
| — | -$6.26M | -$10.09M | -$10.83M | -$5.55M | -$2.71M | -$4.41M | -$3.79M | -$4.03M | -$18.83M | -$3.34M | -$24.95M | -$14.15M | -$25.95M | -$22.67M | -$20.38M | |
| — | -20.4% | -30.05% | -32.47% | -15.35% | -9.03% | -19.11% | -12% | -13.51% | -59.88% | -10.5% | -134.89% | -1545.9% | -4841.04% | -8142.09% | — | |
| -$3.4M | — | — | — | — | — | — | -$3.6M | -$2.91M | -$3.34M | -$3.34M | -$27.91M | -$16.03M | — | — | — | |
| — | — | — | — | — | — | — | — | -$4.03M | -$18.83M | -$3.33M | -$27.91M | $0 | $0 | -$22.67M | -$18.45M | |
| USD/shares | — | -$1.35 | -$2.65 | -$3.10 | — | — | -$1.30 | -$1.10 | -$1.50 | -$28.50 | -$3.10 | — | — | — | — | — |
| USD/shares | — | -$1.35 | -$2.65 | -$3.10 | — | — | -$1.30 | -$1.10 | -$1.50 | -$28.50 | -$7.50 | — | — | — | — | — |
| shares | — | 4.65M | 3.81M | 3.49M | — | — | 3.36M | 3.2M | 1.96M | 271.38K | 1.06M | 853.67K | 529.59K | 4.29M | — | — |
| shares | — | 4.65M | 3.81M | 3.49M | — | — | 3.36M | 3.2M | 1.96M | 271.38K | 1.16M | 853.67K | 529.59K | 4.29M | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
0.24×
Medical Devices median 2.22×
EV/EBIT
—
Medical Devices median 21.72×
P/E (TTM)
—
Medical Devices median 28.52×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Dermatology Recurring Procedures | $21,478,000 | $21,171,000 | $21,530,000 | $23,025,000 | $22,528,000 | $17,409,000 |
| Dermatology Procedures Equipment | $9,218,000 | $12,391,000 | $11,828,000 | $13,136,000 | $7,449,000 | $5,681,000 |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| United States | $20,584,000 | $20,888,000 | $23,028,000 | — |
| Geographic Distribution Other Foreign | $4,861,000 | $5,839,000 | $6,990,000 | $3,713,000 |
| China | $3,355,000 | $4,069,000 | $3,340,000 | $4,751,000 |
| Middle East | $1,896,000 | $2,766,000 | — | — |
| South Korea | — | — | — | $3,716,000 |
| Geographic Distribution Domestic | — | — | — | $23,981,000 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Dermatology Procedures Equipment | $2,442,000 | $4,335,000 | $3,567,000 | $4,959,000 | $2,708,000 | $1,783,000 |
| Dermatology Recurring Procedures | $1,907,000 | -$2,694,000 | -$1,663,000 | $479,000 | $2,602,000 | $2,039,000 |
Operating Margin by Segment (%)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Dermatology Recurring Procedures | 8.9% | -12.7% | -7.7% | 2.1% | 11.6% | 11.7% |
| Dermatology Procedures Equipment | 26.5% | 35% | 30.2% | 37.8% | 36.4% | 31.4% |